Stephen Minger, Ph.D.
Dr. Stephen Minger is a Director at SLM Blue Skies Innovation Ltd. Prior to this, he was Chief Scientist for Life Sciences and Global Director for Research and Development for Cell Technologies at GE.
Dr. Minger received his Ph.D. in Pathology (Neurosciences) in 1992 from the Albert Einstein College of Medicine in New York City. After post-doctoral work in central nervous system gene therapy, neural transplantation and neural stem cell biology at UCSD with Professor Fred “Rusty” Gage, he moved to the UK in 1996 and was appointed a Lecturer in Biomolecular Sciences at King’s College London in 1998. Dr. Minger was appointed a Senior Lecturer in Stem Cell Biology in 2005 and was the Director of the Stem Cell Biology Laboratory from 2002 until joining GE Healthcare in 2009. Dr. Minger was the Stem Cell Expert and a Member of the UK Gene Therapy Advisory Committee (GTAC) at the Department of Health from 2006-2012 and was until recently the Focal Point for Regenerative Medicine, Drug Discovery and Modernisation of Traditional Chinese Medicine in China for the UK Department of Business, Innovation and Skills. Dr. Minger has also been a an external consultant and reviewer to the European Commission Framework Programmes (FP6 and FP7) since 2003 to promote European-wide biomedical research, a member of the Grants Working Group of the California Institute of Regenerative Medicine since 2004, and is a member of the Scientific Advisory Committee of the Canadian Centre for the Commercialization of Regenerative Medicine.